INSTITUTIONAL INVESTORS ONLY: Please enter your zip code to locate an Investment Consultant.
The pace of disruption and magnitude of technological advancement are reshaping the investment landscape.
Harbor Disruptive Innovation seeks long term growth of capital through a diverse exposure to leading edge
transformational companies across market segments.
12/16/2022
12/19/2022
12/19/2022
0.00000
--
0.00000
--
0.00000
--
0.00000
0.00000
4.15
12/17/2021
12/20/2021
12/20/2021
0.00000
--
5.41817
2.13093
0.00000
3.28724
5.41817
0.00000
7.13
12/16/2020
12/17/2020
12/17/2020
0.00000
0.00000
1.93063
0.75288
0.00000
1.17775
1.93063
0.00000
13.33
12/13/2019
12/16/2019
12/16/2019
0.00000
0.00000
2.17058
0.00000
0.00000
2.17058
2.17058
0.00000
9.32
12/14/2018
12/17/2018
12/17/2018
0.00000
0.00000
1.78258
0.25762
0.00000
1.52496
1.78258
0.00000
8.45
12/15/2017
12/18/2017
12/18/2017
0.00000
0.00000
1.21613
0.34479
0.00000
0.87134
1.21613
0.00000
10.38
12/16/2016
12/19/2016
12/19/2016
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
8.83
12/16/2015
12/17/2015
12/17/2015
0.00000
0.06299
1.06091
0.00000
0.00000
1.06091
1.12390
0.00000
8.60
12/17/2014
12/18/2014
12/18/2014
0.00000
0.00000
1.82617
0.26749
0.00000
1.55868
1.82617
0.00000
9.65
12/16/2013
12/17/2013
12/17/2013
0.00000
0.00000
1.83565
0.67261
0.00000
1.16304
1.83565
0.00000
10.34
12/14/2012
12/17/2012
12/17/2012
0.00000
0.00000
0.18749
0.00000
0.00000
0.18749
0.18749
0.00000
9.28
12/15/2011
12/16/2011
12/16/2011
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
7.69
12/16/2010
12/17/2010
12/17/2010
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
8.55
12/17/2009
12/18/2009
12/18/2009
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
6.85
12/18/2008
12/19/2008
12/19/2008
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
5.23
12/18/2007
12/19/2007
12/19/2007
0.00000
0.01032
0.45524
0.24720
0.00000
0.20804
0.46556
0.00000
9.13
12/18/2006
12/19/2006
12/19/2006
0.00000
0.01663
0.03370
0.00000
0.00000
0.03370
0.05033
0.00000
7.97
12/19/2005
12/20/2005
12/20/2005
0.00000
0.00000
0.84516
0.00000
0.00000
0.84516
0.84516
0.00000
7.04
12/29/2004
12/30/2004
12/30/2004
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
6.65
12/29/2003
12/30/2003
12/30/2003
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
6.14
12/27/2002
12/30/2002
12/30/2002
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
4.20
12/26/2001
12/27/2001
12/28/2001
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
6.35
Workday Inc. Class A [WDAY]
22
167.33
3,601
3.6
Lam Research Corporation [LRCX]
8
420.30
3,507
3.5
Adyen NV [ADYEN]
2
1,375.04
3,344
3.4
ServiceNow Inc. [NOW]
9
388.27
3,302
3.3
Amazon.com Inc. [AMZN]
35
84.00
2,975
3.0
Okta Inc. Class A [OKTA]
42
68.33
2,877
2.9
MercadoLibre Inc. [MELI]
3
846.24
2,800
2.8
Microchip Technology Incorporated [MCHP]
37
70.25
2,626
2.7
Cadence Design Systems Inc. [CDNS]
16
160.64
2,609
2.6
T-Mobile US Inc. [TMUS]
17
140.00
2,411
2.4
Ball Corporation [BALL]
46
51.14
2,363
2.4
Texas Instruments Incorporated [TXN]
14
165.22
2,353
2.4
Danaher Corporation [DHR]
8
265.42
2,253
2.3
NextEra Energy Inc. [NEE]
26
83.60
2,149
2.2
Atlassian Corp Class A [TEAM]
15
128.68
1,964
2.0
Snowflake Inc. Class A [SNOW]
12
143.54
1,749
1.8
Alphabet Inc. Class A [GOOGL]
20
88.23
1,747
1.8
Alphabet Inc. Class C [GOOG]
20
88.73
1,732
1.8
Microsoft Corporation [MSFT]
7
239.82
1,717
1.7
Fiserv Inc. [FISV]
17
101.07
1,670
1.7
Cloudflare Inc Class A [NET]
35
45.21
1,599
1.6
ASML Holding NV [ASML]
3
537.68
1,571
1.6
Ascendis Pharma A/S Sponsored ADR [ASND]
12
122.13
1,510
1.5
ICON Plc [ICLR]
7
194.25
1,383
1.4
Block Inc. Class A [SQ]
21
62.84
1,337
1.4
Samsara Inc. Class A [IOT]
107
12.43
1,334
1.4
Progressive Corporation [PGR]
10
129.71
1,233
1.2
Rocket Pharmaceuticals Inc. [RCKT]
61
19.57
1,190
1.2
Chipotle Mexican Grill Inc. [CMG]
1
1,387.49
1,178
1.2
Tesla Inc. [TSLA]
9
123.18
1,126
1.1
Datadog Inc Class A [DDOG]
15
73.50
1,118
1.1
Wolfspeed Inc [WOLF]
16
69.04
1,072
1.1
Insulet Corporation [PODD]
3
294.39
1,002
1.0
Alkermes Public Limited Company [ALKS]
38
26.13
980
1.0
DoorDash Inc. Class A [DASH]
20
48.82
960
1.0
Applied Materials Inc. [AMAT]
10
97.38
939
1.0
DexCom Inc. [DXCM]
8
113.24
935
0.9
HubSpot Inc. [HUBS]
3
289.13
899
0.9
Shopify Inc. Class A [SHOP]
25
34.71
876
0.9
Avidity Biosciences Inc [RNA]
39
22.19
858
0.9
MongoDB Inc. Class A [MDB]
4
196.84
860
0.9
Advanced Micro Devices Inc. [AMD]
13
64.77
824
0.8
CyberArk Software Ltd. [CYBR]
6
129.65
811
0.8
Fortinet Inc. [FTNT]
16
48.89
800
0.8
Sea Ltd. (Singapore) Sponsored ADR Class A [SE]
15
52.03
789
0.8
Smartsheet Inc. Class A [SMAR]
20
39.36
788
0.8
Airbnb Inc. Class A [ABNB]
9
85.50
774
0.8
Salesforce Inc. [CRM]
6
132.59
774
0.8
NVIDIA Corporation [NVDA]
5
146.14
722
0.7
IDEXX Laboratories Inc. [IDXX]
2
407.96
707
0.7
Eli Lilly and Company [LLY]
2
365.84
689
0.7
Replimune Group Inc. [REPL]
25
27.20
689
0.7
Bicycle Therapeutics Plc Sponsored ADR [BCYC]
23
29.60
669
0.7
Cooper Companies Inc. [COO]
2
330.67
669
0.7
Procore Technologies Inc [PCOR]
14
47.18
658
0.7
Arrowhead Pharmaceuticals Inc. [ARWR]
16
40.56
647
0.7
Krystal Biotech Inc. [KRYS]
8
79.22
620
0.6
UnitedHealth Group Incorporated [UNH]
1
530.18
626
0.6
REGENXBIO Inc. [RGNX]
25
22.68
565
0.6
Lantheus Holdings Inc [LNTH]
11
50.96
552
0.6
Thermo Fisher Scientific Inc. [TMO]
1
550.69
550
0.6
Bio-Rad Laboratories Inc. Class A [BIO]
1
420.49
529
0.5
Chart Industries Inc. [GTLS]
5
115.23
526
0.5
Lonza Group AG [LONN]
1
489.73
474
0.5
Repare Therapeutics Inc. [RPTX]
32
14.71
474
0.5
uniQure N.V. [QURE]
20
22.67
461
0.5
Arvinas Inc. [ARVN]
12
34.21
412
0.4
Dynatrace Inc. [DT]
10
38.30
397
0.4
Zscaler Inc. [ZS]
3
111.90
348
0.4
Palo Alto Networks Inc. [PANW]
2
139.54
313
0.3
Deliveroo plc Class A [ROO]
294
1.03
303
0.3
Meta Platforms Inc. Class A [META]
3
120.34
312
0.3
Intellia Therapeutics Inc. [NTLA]
8
34.89
288
0.3
Zoom Video Communications Inc. Class A [ZM]
4
67.74
288
0.3
Sarepta Therapeutics Inc. [SRPT]
2
129.58
277
0.3
Kymera Therapeutics Inc. [KYMR]
11
24.96
268
0.3
Autolus Therapeutics Plc Sponsored ADR [AUTL]
136
1.90
259
0.3
Allogene Therapeutics Inc. [ALLO]
39
6.29
245
0.3
AUTO1 Group SE [AG1]
28
8.32
234
0.2
Catalent Inc [CTLT]
5
45.01
234
0.2
Peloton Interactive Inc. Class A [PTON]
30
7.94
239
0.2
Apellis Pharmaceuticals Inc. [APLS]
4
51.71
215
0.2
Iovance Biotherapeutics Inc [IOVA]
34
6.39
217
0.2
Synlogic Inc [SYBX]
293
0.76
223
0.2
Invitae Corp. [NVTA]
108
1.86
201
0.2
C4 Therapeutics Inc. [CCCC]
23
5.90
138
0.1
Coinbase Global Inc. Class A [COIN]
4
35.39
126
0.1
Karuna Therapeutics Inc. [KRTX]
1
196.50
130
0.1
Precision BioSciences Inc. [DTIL]
102
1.19
122
0.1
Fate Therapeutics Inc. [FATE]
10
10.09
102
0.1
Freeline Therapeutics Holdings Plc Sponsored ADR [FRLN]
121
0.48
58
0.1
Magenta Therapeutics Inc [MGTA]
149
0.40
59
0.1
TCR2 Therapeutics Inc. [TCRR]
63
1.00
63
0.1
Carvana Co. Class A [CVNA]
9
4.74
45
0.0
Total
--
--
--
96,207
97.4
Cash and Other Assets Less Liabilities
--
--
--
--
2.6
Total Net Assets
--
--
--
--
100%
Disruptive Innovation Fund (HNMGX)
S&P 500 Index
Information Technology
HNMGX: 50.1%
Benchmark: 25.8%
Health Care
HNMGX: 22.8%
Benchmark: 15.8%
Consumer Discretionary
HNMGX: 10.7%
Benchmark: 9.8%
Communication Services
HNMGX: 7.0%
Benchmark: 7.3%
Materials
HNMGX: 2.4%
Benchmark: 2.8%
Utilities
HNMGX: 2.2%
Benchmark: 3.2%
Financials
HNMGX: 1.4%
Benchmark: 11.7%
Industrials
HNMGX: 0.5%
Benchmark: 8.6%
Consumer Staples
HNMGX: 0.0%
Benchmark: 7.2%
Energy
HNMGX: 0.0%
Benchmark: 5.2%
Real Estate
HNMGX: 0.0%
Benchmark: 2.7%
HNMGX: Disruptive Innovation Fund
Benchmark: S&P 500 Index
Health Care
7.9
12.8
Utilities
7.1
8.6
Materials
6.2
15.0
Information Technology
0.4
4.7
Energy
0.0
22.8
Real Estate
0.0
3.8
Consumer Staples
0.0
12.7
Communication Services
-9.2
-1.4
Consumer Discretionary
-21.0
-10.2
Financials
-35.3
13.6
Industrials
-50.4
19.2
The Fund employs a multi-manager approach in an effort to achieve its investment objective, offering the expertise of multiple investment managers in one Fund. As the fund sponsor, Harbor Capital assumes responsibility for selecting and overseeing underlying managers for the Fund. Each underlying manager is responsible for submitting a model portfolio to Harbor Capital, which the portfolio managers will implement in their discretion. The portfolio managers will handle the assigned allocation within the fund and will adjust over time based upon both qualitative and quantitative assessments of each strategy in an effort to enhance the investment outcome for the Fund.
From time to time, certain fees and/or expenses have been voluntarily or contractually waived or reimbursed, which has resulted in higher returns. Without these waivers or reimbursements, the returns would have been lower. Voluntary waivers or reimbursements may be applied or discontinued at any time without notice. Only the Board of Trustees may modify or terminate contractual fee waivers or expense reimbursements.
As a result of changing market conditions, total net asset levels, expenses and other factors may change at any time during the current fiscal period and may differ from those shown.
There is no guarantee that the investment objective of the Fund will be achieved. Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. Investing in REITs will subject the Fund to additional risk. Investing in international and emerging markets poses special risks, including potentially greater price volatility due to social, political and economic factors, as well as currency exchange rate fluctuations. These risks are more severe for securities of issuers in emerging market regions.
Weighted Average Market Capitalization: The average size of the companies in a portfolio or index as measured by the market value of outstanding shares.
Price/Book: The price-to-book (P/B) ratio evaluates a firm's market value relative to its book value.
Adjusted Trailing P/E Ratio: The Adjusted Trailing P/E (Price/Earnings) Ratio is the closing stock price divided by the sum of the last 12 months actual EPS.
% EPS Growth – Past 3 year: Earnings per share refers to the bottom-line measure of a company’s profitability defined as net income divided by the number of outstanding shares.
Return on Equity: Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.
Forecasted P/E Ratio: a measure of the P/E (price-to-earnings) ratio using forecasted earnings for the P/E calculation.
2643822